ClinicalTrials.gov
public full text
Public Domain
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-Pentixafor PET imaging in patients with primary aldosteronism. And evaluates the potential of Al18F-NOTA-Pentixafor PET imaging in surgical strategy guidance.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection#1032162
- Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients#1058137
- PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning#1171866
- Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification#804889
- A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers#321669
Record · ID 1075028
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive